These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8412015)

  • 1. Non-ketotic hyperglycinaemia: molecular lesion, diagnosis and pathophysiology.
    Tada K; Kure S
    J Inherit Metab Dis; 1993; 16(4):691-703. PubMed ID: 8412015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ketotic hyperglycinemia: a life-threatening disorder in the neonate.
    Tada K; Kure S; Takayanagi M; Kume A; Narisawa K
    Early Hum Dev; 1992; 29(1-3):75-81. PubMed ID: 1396281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of placental enzyme analysis in assessment of the newborn at risk for non-ketotic hyperglycinaemia (NKH).
    Toone JR; Applegarth DA
    J Inherit Metab Dis; 1989; 12(3):281-5. PubMed ID: 2515368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic analysis of non-ketotic hyperglycinaemia: a partial deletion of P-protein gene.
    Tada K; Kure S; Kume A; Hiraga K
    J Inherit Metab Dis; 1990; 13(5):766-70. PubMed ID: 2246863
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel mutations in the P-protein (glycine decarboxylase) gene in patients with glycine encephalopathy (non-ketotic hyperglycinemia).
    Toone JR; Applegarth DA; Kure S; Coulter-Mackie MB; Sazegar P; Kojima K; Ichinohe A
    Mol Genet Metab; 2002 Jul; 76(3):243-9. PubMed ID: 12126939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a common mutation in Finnish patients with nonketotic hyperglycinemia.
    Kure S; Takayanagi M; Narisawa K; Tada K; Leisti J
    J Clin Invest; 1992 Jul; 90(1):160-4. PubMed ID: 1634607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-ketotic hyperglycinemia].
    Kálmánchey R; Szücs L; Majtényi K; Liptai Z; Dobos M; Krause I; Nagy I
    Orv Hetil; 1995 Jan; 136(5):245-9. PubMed ID: 7772127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems of prenatal diagnosis of non-ketotic hyperglycinaemia.
    von Wendt L; Similä S; Ruokonen A; Hartikainen-Sorri AL
    J Inherit Metab Dis; 1983; 6(3):112-3. PubMed ID: 6422141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ketotic hyperglycinemia: an aim of the second generation of studies on pathogenesis.
    Hiraga K; Koyata H; Sakakibara T; Ishiguro Y; Matsui C
    Mol Biol Med; 1991 Feb; 8(1):65-79. PubMed ID: 1943691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of mutations in the glycine decarboxylase gene in patients with nonketotic hyperglycinaemia.
    Sellner L; Edkins E; Greed L; Lewis B
    Mol Genet Metab; 2005 Feb; 84(2):167-71. PubMed ID: 15670722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and expression of the glycine cleavage system in rat central nervous system.
    Sakata Y; Owada Y; Sato K; Kojima K; Hisanaga K; Shinka T; Suzuki Y; Aoki Y; Satoh J; Kondo H; Matsubara Y; Kure S
    Brain Res Mol Brain Res; 2001 Oct; 94(1-2):119-30. PubMed ID: 11597772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonketotic hyperglycinemia: biochemical, molecular, and neurological aspects.
    Kure S; Tada K; Narisawa K
    Jpn J Hum Genet; 1997 Mar; 42(1):13-22. PubMed ID: 9183995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of non-ketotic hyperglycinaemia.
    Toone JR; Applegarth DA; Levy HL
    J Inherit Metab Dis; 1992; 15(5):713-9. PubMed ID: 1434509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and expression analyses of normal and mutant mRNA encoding glycine decarboxylase: three-base deletion in mRNA causes nonketotic hyperglycinemia.
    Kure S; Narisawa K; Tada K
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1176-82. PubMed ID: 1996985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.
    Kanno J; Hutchin T; Kamada F; Narisawa A; Aoki Y; Matsubara Y; Kure S
    J Med Genet; 2007 Mar; 44(3):e69. PubMed ID: 17361008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effects of serine medication in non-ketotic hyperglycinaemia due to deficiency of P-protein of the glycine cleavage complex.
    Wijburg FA; de Groot CJ; Schutgens RB; Barth PG; Tada K
    J Inherit Metab Dis; 1988; 11 Suppl 2():218-20. PubMed ID: 3141706
    [No Abstract]   [Full Text] [Related]  

  • 17. One-methyl group metabolism in non-ketotic hyperglycinaemia: mildly elevated cerebrospinal fluid homocysteine levels.
    Van Hove JL; Lazeyras F; Zeisel SH; Bottiglieri T; Hyland K; Charles HC; Gray L; Jaeken J; Kahler SG
    J Inherit Metab Dis; 1998 Dec; 21(8):799-811. PubMed ID: 9870205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impaired expression of glycine decarboxylase in patients with hyperglycinemias.
    Kume A; Kure S; Tada K; Hiraga K
    Biochem Biophys Res Commun; 1988 Jul; 154(1):292-7. PubMed ID: 3395333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal non-ketotic hyperglycinemia (NKH). Diagnoses and management in two cases.
    Holmqvist P; Polberger S
    Neuropediatrics; 1985 Nov; 16(4):191-3. PubMed ID: 4080094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension associated with nonketotic hyperglycinaemia.
    Cataltepe S; van Marter LJ; Kozakewich H; Wessel DL; Lee PJ; Levy HL
    J Inherit Metab Dis; 2000 Mar; 23(2):137-44. PubMed ID: 10801055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.